Fate Therapeutics (FATE) PT Raised to $88 at Mizuho Securities as Data Derisks the Technology
Tweet Send to a Friend
Mizuho Securities analyst Mara Goldstein raised the price target on Fate Therapeutics (NASDAQ: FATE) to $88.00 (from $40.00) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
